---
title: "The smart medical sector opened high, with PR rising over 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237479725.md"
description: "The smart medical sector opened high, with PR rising over 8%, HESH rising over 7%, and several stocks including Ganli Pharmaceutical, Chuangye Huikang, and Saili Medical opening high. In terms of news, the Ministry of Industry and Information Technology and six other departments issued the \"Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry,\" proposing to carry out pilot applications for \"AI Empowering the Entire Pharmaceutical Industry Chain.\""
datetime: "2025-04-25T01:28:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237479725.md)
  - [en](https://longbridge.com/en/news/237479725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237479725.md)
---

# The smart medical sector opened high, with PR rising over 8%

The smart medical sector opened high, with PR rising over 8%, HESH rising over 7%, and several stocks including Ganli Pharmaceutical, Chuangye Huikang, and Saili Medical opening high. On the news front, the Ministry of Industry and Information Technology and six other departments issued the "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry," proposing to carry out pilot applications for "AI Empowering the Entire Pharmaceutical Industry Chain."

### Related Stocks

- [301230.CN](https://longbridge.com/en/quote/301230.CN.md)
- [301103.CN](https://longbridge.com/en/quote/301103.CN.md)
- [300451.CN](https://longbridge.com/en/quote/300451.CN.md)
- [603716.CN](https://longbridge.com/en/quote/603716.CN.md)
- [603087.CN](https://longbridge.com/en/quote/603087.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [India's lifeline ferry across strategic archipelago](https://longbridge.com/en/news/286716580.md)
- [Orion Pharma to reveal initial results from Phase 1/2 TEADES study of ODM-212 at 2026 ASCO® Meeting.](https://longbridge.com/en/news/287177935.md)
- [Shanghai Henlius says China regulator clears HLX48 Phase 1 trial IND for solid tumors](https://longbridge.com/en/news/287189347.md)
- [Lula ahead of Bolsonaro in Brazil presidential vote poll](https://longbridge.com/en/news/286896793.md)